SecuritySSD / Simpson Manufacturing Co., Inc. (829073105)
IndustryCutlery, Handtools, And General Hardware
Common Stock Shares Outstanding46,745,000 shares (as of 2017-12-31)
Total Insiders18
Total Directors10
Total Officers6

Stock Insider Trading (from SEC Form 4)

Simpson Manufacturing Co., Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

SSD / Simpson Manufacturing Co., Inc. insiders include BLESS MICHAEL A, Mackenzie Jeffrey Eric, SIMPSON PSB FUND, Leung Sunny H, Dankel Roger, CHATMAN JENNIFER, FORD CELESTE VOLZ, Magstadt Brian J, Colonias Karen Winifred, Arevalo Ricardo M, CUSUMANO GARY M, Swartzendruber Kevin Lee LOURAS PETER N, MACGILLIVRAY GREENWAY ROBIN, Donaldson Philip E, and SIMPSON SHARON H, FITZMYERS THOMAS J, ANDRASICK JAMES S, .

Insider Roster

Insider Dir Off 10% Shares Owned
BLESS MICHAEL A Director
X 2,913
CHATMAN JENNIFER Director
X 12,363
ANDRASICK JAMES S Director
X 10,938
MACGILLIVRAY GREENWAY ROBIN Director
X 12,363
LOURAS PETER N Director
X 18,521
CUSUMANO GARY M Director
X 18,163
FORD CELESTE VOLZ Director
X 9,609
Donaldson Philip E Director
X 1,475
SIMPSON PSB FUND
382,541
SIMPSON SHARON H 10% Owner
X 493,270
Swartzendruber Kevin Lee Senior VP of Finance
X
Dankel Roger President, Simpson Strong-Tie
X 33,529
Arevalo Ricardo M COO, Simpson Strong-Tie
X 36,053
Magstadt Brian J Chief Financial Officer
X 57,137
Colonias Karen Winifred President & CEO, Director
X X 137,934
Leung Sunny H
Mackenzie Jeffrey Eric
FITZMYERS THOMAS J Vice Chairman of the Board, Director
X X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-04-24 4 Donaldson Philip E A D 55.34 1,475 1,475
2018-04-24 4 FORD CELESTE VOLZ A D 55.34 1,475 9,609
2018-04-24 4 CUSUMANO GARY M A D 55.34 1,475 18,163
2018-04-24 4 LOURAS PETER N A D 55.34 1,475 18,521
2018-04-24 4 MACGILLIVRAY GREENWAY ROBIN A D 55.34 1,475 12,363
2018-04-24 4 ANDRASICK JAMES S A D 55.34 1,475 10,938
2018-04-24 4 CHATMAN JENNIFER A D 55.34 1,475 12,363
2018-04-24 4 BLESS MICHAEL A A D 55.34 1,475 2,913
2018-04-16 4 SIMPSON PSB FUND S D 57.355 -36,274 382,541 21,940,639
2018-04-16 4 SIMPSON PSB FUND S D 57.50 -48,409 418,815 24,081,862
2018-04-16 4 SIMPSON PSB FUND S D 57.075 -25,646 467,224 26,666,810
2018-04-09 4 SIMPSON PSB FUND S D 57.053 -200 492,870 28,119,712
2018-04-09 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.053 200 493,270 28,142,533
2018-04-06 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.322 -7,915 493,070 28,263,759
2018-04-05 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.965 -22,773 500,985 29,039,596
2018-04-04 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.347 -21,553 523,758 30,035,950
2018-04-02 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.203 -3,665 545,311 31,193,425
2018-03-29 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.68 -42,419 548,976 31,664,936
2018-03-28 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.142 -21,181 591,395 33,793,493
2018-03-27 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.265 -14,655 612,576 35,079,165
2018-03-26 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.50 -50,000 627,231 36,065,782
2018-02-27 4 SIMPSON SHARON H By non-profit public benefit corporation S I 57.652 -42,038 677,231 39,043,722
2018-02-26 4 SIMPSON SHARON H By non-profit public benefit corporation S I 58.50 -27,550 719,269 42,077,236
2018-04-06 4 SIMPSON PSB FUND S D 57.322 -7,915 493,070 28,263,759
2018-04-05 4 SIMPSON PSB FUND S D 57.965 -22,773 500,985 29,039,596
2018-04-04 4 SIMPSON PSB FUND S D 57.347 -21,553 523,758 30,035,950
2018-04-02 4 SIMPSON PSB FUND S D 57.203 -3,665 545,311 31,193,425
2018-03-29 4 SIMPSON PSB FUND S D 57.68 -42,419 548,976 31,664,936
2018-03-28 4 SIMPSON PSB FUND S D 57.142 -21,181 591,395 33,793,493
2018-03-27 4 SIMPSON PSB FUND S D 57.265 -14,655 612,576 35,079,165
2018-03-26 4 SIMPSON PSB FUND S D 57.50 -50,000 627,231 36,065,782
2018-02-27 4 SIMPSON PSB FUND S D 57.652 -42,038 677,231 39,043,722
2018-02-26 4 SIMPSON PSB FUND S D 58.50 -27,550 719,269 42,077,236
2018-04-02 4 SIMPSON SHARON H By Trust S I 57.203 -3,665 4,133,127 236,427,264
2018-03-29 4 SIMPSON SHARON H By Trust S I 57.68 -42,419 4,136,792 238,610,163
2018-03-28 4 SIMPSON SHARON H By Trust S I 57.142 -21,181 4,179,211 238,808,475
2018-03-27 4 SIMPSON SHARON H By Trust S I 57.265 -14,655 4,200,392 240,535,448
2018-03-26 4 SIMPSON SHARON H By Trust S I 57.50 -50,000 4,215,047 242,365,202
2018-02-27 4 SIMPSON SHARON H By Trust S I 57.652 -42,038 4,265,047 245,888,490
2018-02-26 4 SIMPSON SHARON H By Trust S I 58.50 -27,550 4,307,085 251,964,472
2018-02-22 4 SIMPSON SHARON H By Trust S I 57.939 -1,267 4,334,635 251,144,417
2018-02-21 4 SIMPSON SHARON H By Trust S I 57.769 -29,107 4,335,902 250,480,723
2018-02-20 4 SIMPSON SHARON H By Trust S I 57.336 -21,840 4,365,009 250,272,156
2018-02-16 4 SIMPSON SHARON H By Trust S I 57.724 -26,000 4,386,849 253,226,472
2018-02-15 4 SIMPSON SHARON H By Trust S I 57.627 -33,815 4,412,849 254,299,249
2018-02-15 4 Colonias Karen Winifred A D 13,956 137,934
2018-02-15 4 Magstadt Brian J A D 5,017 57,137
2018-02-15 4 Arevalo Ricardo M A D 3,876 36,053
2018-02-15 4 Dankel Roger A D 3,876 33,529
2018-02-01 4 SIMPSON SHARON H By Trust S I 59.086 -23,447 4,446,664 262,735,589
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

Related News Stories

Aegion (AEGN) Beats on Q1 Earnings & Sales, Affirms View

2018-05-03 zacks
Aegion Corporation (AEGN - Free Report) reported first-quarter 2018 adjusted earnings of 13 cents per share, which declined 28% year over year. Earnings, however, beat the Zacks Consensus Estimate by a penny. Including one-time items, Aegion reported loss of 6 cents per share in the quarter, against earnings of 17 cents per share posted in the prior-year quarter. Operational Update Total revenues in the quarter remained flat year over year, at $325 million, as record revenues of the Energy Services segment were offset by lost contribution from the large deepwater pipe coating and insulation project. (11-0)

Simpson Manufacturing's (SSD) CEO Karen Colonias on Q1 2018 Results - Earnings Call Transcript

2018-05-01 seekingalpha
Simpson Manufacturing Co., Inc. (NYSE:SSD) Q1 2018 Earnings Conference Call April 30, 2018 5:00 PM ET (13-0)

Stocks To Watch: Apple, FOMC And China On Tap

2018-04-28 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (1078-2)

Armstrong World Poised to Gain From Rising AUV, Tax Reform

2018-03-06 zacks
On Mar 5, we issued an updated research report on Armstrong World Industries, Inc. (AWI - Free Report) . The company is poised to gain from average unit value (AUV) improvement and tax reform. The company’s focus on restructuring activities, investment in new products, as well as the Tectum acquisition are also anticipated to drive growth. Let’s illustrate these growth factors in detail. Rising AUV to Boost Top Line Armstrong World posted strong sales in fourth-quarter 2017, marking 9% year-over-year growth. (17-0)

Simpson Manufacturing's (SSD) CEO Karen Colonias on Q4 2017 Results - Earnings Call Transcript

2018-02-06 seekingalpha
Simpson Manufacturing Co., Inc. (NYSE:SSD) Q4 2017 Earnings Conference Call February 5, 2018 5:00 PM ET (13-0)